Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 1, 2000 - Issue 4
Journal homepage
145
Views
56
CrossRef citations to date
0
Altmetric
Research Article

Amyotrophic lateral sclerosis: toxins and environment

JD Mitchell Department of Neurology, Royal Preston Hospital, UK
Pages 235-250 | Published online: 10 Jul 2009

  • Jones CT, Swingler R), Simpson SA, Brock DJ. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-292.
  • Al-Chalabi A, Andersen PM, Chioza B, et al. Recessive amyotrophic lateral sclerosis families with the D90A SODl mutation share a common founder; evidence for a linked protective factor. Hum Mol Genet 1998; 7: 2045-2050.
  • Robberecht W, Aguirre T, Van den Bosch L, et al. D90A heterozygosity in the SODl gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996; 47: 1336-1339.
  • Ceroni M, Malaspina A, Poloni TE, et al. Clustering of ALS patients in central Italy due to the occurrence of the LS4F SODl gene mutation. Neurology 1999; 53: 1064-1071.
  • Orrell RW, Habgood J, Rudge P, et al. Difficulties in distinguishing sporadic from familial amyotrophic lateral sclerosis. Ann Neurol 1996: 39: 810-812.
  • Neilson S, Robinson 1. Cross-sectional Gompertzian analysis: the development of a Gompertz mortality ratio (GMR) and its applicability. Mech Ageing Dev 1993; 68: 137-149.
  • Neilson S, Robinson 1. Reinterpreting mortality statistics: some uses of Gompertzian analysis in epidemiological research. J Clin Epidemiol 1993; 46: 1063-1069.
  • Martyn CN. Epidemiology. In: Williams AC, ed. Motor Neuron Disease. London: Chapman & Hall, 1994: 393-426.
  • Bettoni L, Bazzani M, Bortone E, Dascola 1, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960-1990. Acta Neurol Scand 1994; 90: 276-280.
  • The Scottish Motor Neuron Disease Research Group. The Scottish motor neuron disease register: a prospective study of adult motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992; 55: 536-541.
  • Gunnarsson LG, Bodin L, Soderfeldt B, Axelson O. A case control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992; 49: 791-798.
  • Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs Rl. Amyotrophic lateral sclerosis and occupational history. A pilot case control study. Arch Neurol 1996: 53: 730-733.
  • Rosati G, Pinna E, Granieri E, et al. Studies on epidemiological, clinical and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977; 55: 231-244.
  • Holloway SM, Emeiy AEH. The epidemiology of motor neuron disease in Scotland. Muscle & Nerve 1982; 5: 131-133.
  • Giagheddu M, Puggoni G, Masala C, et al. Epidemiologie study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand 1983; 68: 394-404.
  • Armon C, Kurland ET, Daube JR, O'Brien PC. Epidemiologie correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991; 41: 1077-1084.
  • Gunnarsson EG, Eindberg G, Soderfeldt B, Axelson O. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand 1991; 83: 394-398.
  • Gunnarsson EG, Eygner PE, Veiga-Cabo J, de Pedro-Cuesta J. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. Neuroepidemiology 1996; 15: 142-152.
  • McGuire V, Eongstreth WT, Jr, Nelson EM, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997; 145: 1076-1088.
  • Panse F. Electrical lesions of the nervous system. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology Vol. 7. Amsterdam: North Holland, 1970: 344-387.
  • Holbrook EA, Beach FXM, Silver JR. Delayed myelopathy: a rare complication of severe electrical burns. Br Med J 1970; iv: 659-660.
  • Parrel 1 DF, Starr A. Delayed neurological sequelae of electrical injuries. Neurology 1968; 18: 601-606.
  • Panse F. Die Schädigungen des Nervensystems durch technische Elektrizität. Monatschr Psychiat Neurol 1931; 78: 193-221.
  • Haynal A, Regli F. Zusammenhang der amyotrophischen lateralsklerose mit gehäuften Elektrotraumata. Confin Neurol 1964; 24: 189-198.
  • Gawel M, Zaiwalla A, Rose FC. Antecedent events in motor neuron disease. J Neurol Neurosurg Psychiatiy 1983; 46: 1041-1043.
  • Deapen BM, Henderson BE. A case control study of amyotrophic lateral sclerosis. Am J Epidemiol 1986; 123: 790-799.
  • Nelson EM. Epidemiology of AES. Clin Neurosci 1995-96; 3:327-331.
  • Johansen C, Olsen JH. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol 1998; 148: 362-368.
  • Savitz DA, Checkoway H, Eoomis, DP. Magnetic field exposure and neurodegenerative disease mortality among electric utility workers. Epidemiology 1998; 9: 398-404.
  • Kondo K, Tsubaki T. Case-control studies of motor neuron disease: association with mechanical injuries. Arch Neurol 1981; 38: 220-226.
  • Neilson S, Robinson 1, Clifford Rose F. Mortality from motor neuron disease in Japan, 1950-1990: association with radioactive fallout from atmospheric weapons testing. J Neurol Sci 1995; 134: 61-66.
  • Neilson S, Robinson 1, Clifford Rose F. Ecological correlates of motor neuron disease mortality: a hypothesis concerning an epidemiological association with radon gas and gamma exposure. J Neurol 1996; 243: 329-336.
  • Campbell AMG, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatiy 1970; 33: 877-885.
  • Gresham LS, Molgaard CA, Golbeck AL, et al. Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case control study. Neuroepidemiology 1986; 5: 29-38.
  • Rosati G, Pinna L, Granieri E, et al. Studies on epidemiological, clinical and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977; 55: 231-244.
  • Kurland LT, Radhakrishnan K, Smith GE, et al. Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiological evidence. J Neurol Sci 1992; 113: 133-143.
  • Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses 1991; 34: 144-148.
  • Hastings KEM. Gene expression in motor neurons. In: Smith RA, ed. Handbook of Amyotrophic Lateral Sclerosis. New York: Marcel Dekker, 1992: 709-737.
  • Kanter M. Free radicals, exercise and antioxidant supplementation. Proc NutrSoc 1998; 57: 9-13.
  • Kamel F, Umbach DM, Munsat TL, et al. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 1999; 18: 194-202.
  • Harnisch R, Dworsky RL, Henderson BE. A search for clues to the cause of amyotrophic lateral sclerosis. Arch Neurol 1976; 33: 456-457.
  • Hawkes CH, Fox J. Motor neurone disease in leather workers. Lancet 1981; i: 507.
  • Buckley J, Warlow C, Smith P, et al. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatiy 1983; 46: 197-205.
  • Holloway SM, Mitchell JD. Motor neurone disease in the Lothian region of Scotland 1961-81. ) Epidem Commun Health 1986; 40: 344-350.
  • Hawkes CH, Cavanagh JB, Fox AJ. Motoneuron disease: a disorder secondaiy to solvent exposure? Lancet 1989; i: 73-76.
  • Chancellor AM, Slattery JM, Fraser H, et al. Risk factors for motor neuron disease: a case- control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1993; 56: 1200-1206.
  • Waldron HA. Lead poisoning in the ancient world. Med Hist 1973; 17:391-399.
  • Romberg MH. Lehrbuch der Nervenkrankheiten des Menschen (2nd edn). (Originally published Berlin: Duncker) Trans & ed. Sieveking (1853), London: Sydenham Society, 1851: 371-375.
  • Bell C. The nervous system of the human body. (3rd edn). London: Longmans, 1836, 432-434.
  • Aran FA. Recherches sur une maladie non encore decrite du système musculaire. Arch Gen Med (4me Ser) 1850; 24: 1-35.
  • Wilson SAK. The amyotrophy of chronic lead poisoning: amyotrophic lateral sclerosis of toxic origin. Rev Neurol Psychiatry 1907; 5: 441-455.
  • Currier RD, Haerer AF. Amyotrophic lateral sclerosis and metallic toxins. Arch Environ Health 1968; 17: 712-719.
  • Felmus MT, Patten BM, Swanke L. Antecedent events in amyotrophic lateral sclerosis Neurology 1976; 26: 176-178.
  • Pierce Ruhland R, Patten BM. Repeat study of antecedent events in motor neurone disease. Ann Clin Res 1981; 13: 102-107.
  • Roelofs-Iverson RA, Mulder DW, Elveback LR, et al. ALS and heavy metals: a pilot case control study. Neurology 1984; 34: 393-395.
  • Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand 1988; 77: 456-460.
  • Guidetti D, Bondavalli M, Sabadini R, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996; 15: 301-312.
  • Conradi S, Ronnevi LO, Vesterberg O. Increased plasma levels of lead in amyotrophic lateral sclerosis compared to controls as measured by flameless atomic absorption spectrophotometiy. J Neurol Neurosurg Psychiatiy 1978; 41: 389-393.
  • Conradi S, Ronnevi EO, Vesterberg O. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. ) Neurol Sci 1976; 29: 259-265.
  • Conradi S, Ronnevi LO, Nise G, et al. Abnormal distribution of lead in amyotrophic lateral sclerosis. Reestimation of lead in the cerebrospinal fluid, J Neurol Sci 1980; 48: 413-418.
  • House AO, Abbot RJ, Davidson DEW, et al. Response to penicillamine of lead concentrations in CSF and blood of patients with motor neurone disease. Br Med J 1978; ii: 1684.
  • Stober T, Stehe W, Kunze K. Eead concentrations in blood, plasma, erythrocytes and cerebrospinal fluid in amyotrophic lateral sclerosis J Neurol Sci 1983; 61: 21-26.
  • Petkau A, Sawatzky A, Millier CR, et al. Eead content of neuromuscular tissue in amyotrophic lateral sclerosis - case report and other considerations. Br J lndust Med 1974; 31: 275-287.
  • Conradi S, Ronnevi EO, Vesterberg O. Eead concentration in skeletal muscle in amyotrophic lateral sclerosis patients and control subjects. J Neurol Neurosurg Psychiatry 1978; 41: 1001-1004.
  • Kurlander HM, Patten BM. Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol 1979; 6: 21-24.
  • Mandybur Tl, Cooper GP. Increased spinal cord lead content in amyotrophic lateral sclerosis - possibly a secondary phenomenon. Med Hypotheses 1979; 5: 1313-1315.
  • Campbell AMG. Calcium versenate in motor neurone disease. Eancet 1955; ii: 376-377.
  • Simpson JA, Seaton DA, Adams JF. Response to treatment with chelating agents of anaemia, chronic encephalopathy and myelopathy due to lead poisoning. J Neurol Neurosurg Psychiatry 1964; 27: 536-541.
  • Eivesley B, Sissons SE. Chronic lead intoxication mimicking motor neurone disease. Br Med J 1968; iv: 387-388.
  • Conradi S, Ronnevi LO, Nise G, et al. Eong-time penicillamine treatment in amyotrophic lateral sclerosis with parallel determinations of lead in blood, plasma and urine. Acta Neurol Scand 1982; 65: 203-211.
  • Brown IA. Chronic mercurialism - a cause of the clinical syndrome of amyotrophic lateral sclerosis. Arch Neurol Psychiatiy 1954; 72: 674-681.
  • Kantarjian AD. A syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism. Neurology 1961; 11: 639-644.
  • Barber TE. Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med 1978; 20: 667-669.
  • Adams CR, Ziegler DK, Lin JT. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA 1983; 250: 642-643.
  • Kilness AW, Hochberg FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA 1977; 237: 2843-2844.
  • Morris FH, U KS. Amyotrophic lateral sclerosis and low urinary selenium levels. JAMA 1978; 239: 404.
  • Nagata H, Miyata S, Nakamura S, et al. Heavy metal concentrations in blood cells in patients with amyotrophic lateral sclerosis. J Neurol Sci 1985; 67: 173-178.
  • Larsen NA, Pakkenberg H, Damsgaard E, et al. Topographical distribution of arsenic, manganese and selenium in the normal human brain. J Neurol Sci 1979; 42: 407-416.
  • Larsen NA, Pakkenberg H, Damsgaard E, et al. Distribution of arsenic, manganese and selenium in the human brain in chronic renal insufficiency, Parkinson's disease and amyotrophic lateral sclerosis. J Neurol Sci 1981; 51: 437-446.
  • Vinceti M, Guidetti D, Pinotti M, et al. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology 1996; 7: 529-532.
  • Voss H. Progressive Bulbärparalyse und amyotrophische Lateralsklerose nach chronischer Manganvergiftung. Arch Gewebepath Gewebehyg 1939; 9: 464-476.
  • Yase Y, Kumamoto T, Yoshimasu F, et al. Amyotrophic lateral sclerosis studies using neutron activation analysis. Neurology India 1968; 16: 46-50.
  • Yoshimasu F, Vebeyashi Y, Yase Y, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis. Folia Psychiat Neurol Jpn 1976; 30: 49-55.
  • Yoshimasu F, Yasui M, Yase Y, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis. 2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases. Folia Psychiatiy Neurol Jpn 1980; 34: 75-82.
  • Yoshimasu F, Yasui M, Yase Y, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis. 3. Systematic analysis of metals on Guamian ALS and PD cases. Folia Psychiatr Neurol Jpn 1982; 36: 173-180.
  • Miyata S, Nakamura S, Nagata H, et al. Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J Neurol Sci 1983; 61: 283-293.
  • Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837; 1: 41-42.
  • Cotzias GC, Horiuchi K, Fuenzalida S, et al. Chronic manganese poisoning. Clearance of tissue manganese concentrations with persistence of the neurological picture. Neurology 1968; 18: 376-382.
  • Meyers KR, Dorencamp DG, Suzuki K. Amyotrophic lateral sclerosis with diffuse neurofibrillary changes. Arch Neurol 1974; 30: 84-89.
  • Crapper DR, Krishman SS, Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain 1976; 99: 67-80.
  • Klatzo I, Wisniewski H, Streicher E. Experimental production of neurofibrillaiy degeneration. 1. Light microscopic observations. J Neuropath Exp Neurol 1965; 24: 187-199.
  • Yates CM, Gordon A, Wilson H. Neurofibrillaiy degeneration induced in the rabbit by aluminium chloride: aluminium neurofibrillary tangles. J Neuropathol Appl Neurobiol 1976; 2: 131-144.
  • De-Boni U, Otros A, Scott JW, et al. Neurofibrillary degeneration induced by systemic aluminium. Acta Neuropathol (Berlin) 1976; 35: 285-294.
  • Hirano A. Progress in the pathology of motor neurone disease. Prog Neuropathol 1973; 2: 181-215.
  • Garruto, RM, Swyt C, Fiori CE, et al. Intraneuronal deposition of calcium and aluminium in amyotrophic lateral sclerosis of Guam. Lancet 1985; ii: 1353.
  • Kjellin KG. The CSF iron in patients with neurological diseases. Acta Neurol Scand 1967; 43: 299-313.
  • Mitchell JD, East BW, Harris IA, Pentland B. Manganese, selenium and other trace elements in spinal cord, liver and bone in motor neurone disease. Eur Neurol 1991; 31: 7-11.
  • Schanne FAY, Kane AB, Young EE, et al. Calcium dependence of toxic cell death: a final common pathway. Science 1979; 206: 700-702.
  • Hochberg FH, Bryan JA, Whelan MA. Clustering of amyotrophic lateral sclerosis. Eancet 1974; i: 34.
  • Melmed C, Krieger C. Clustering of amyotrophic lateral sclerosis. Arch Neurol 1982; 39: 595-596.
  • Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989; 42: 569-575.
  • Sienko DG, Davis JP, Taylor JA, et al. Amyotrophic lateral sclerosis. A case control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990; 47: 38-41.
  • Proctor SP, Feldman RG, Wolf PA, et al. A perceived cluster of amyotrophic lateral sclerosis in a Massachusetts community. Neuroepidemiology 1992; 1: 277-281.
  • Armon C, Daube JR, O'Brien PC, et al. When is an apparent excess of neurologic cases epidemiologically significant? Neurology 1991; 41: 1713-1718.
  • Mitchell JD, Gibson HN, Gatrell AC. Amyotrophic lateral sclerosis in Lancashire and South Cumbria 1976-86. Arch Neurol 1990; 47: 875-880.
  • Mitchell JD, Gatrell AC, Al-Hamad A, et al. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and South Cumbria. J Neurol Neurosurg Psychiatry 1998; 65: 842-847.
  • Hyser CL, Kissel JT, Mendell JR. Three cases of amyotrophic lateral sclerosis in a common occupational environment. J Neurol 1987; 234: 443-444.
  • Chad D, Mitsumoto H, Adelman LS, et al. Conjugal motor neurone disease. Neurology 1982; 32: 306-307.
  • Camu W, Cadilhac J, Billiard M. Conjugal amyotrophic lateral sclerosis: a report on two couples from southern France. Neurology 1994; 44: 547-548.
  • Poloni M, Micheli A, Facchetti D. Conjugal amyotrophic lateral sclerosis: toxic clustering or chance? Ital J Neurol Sci 1997; 18: 109-112.
  • Martyn CN, Osmond C. The environment in childhood and risk of motor neuron disease. J Neurol Neurosurg Psychiat 1992; 55: 997-1001.
  • Mitchell JD, Davies RB, Al-Hamad A, et al. MND risk factors: an epidemiological study in the North West of England. J Neurol Sci 1995; 129 (suppl): 61-64.
  • Gajdusek DC, Salazar AM. Amyotrophic lateral sclerosis and Parkinsonian syndromes in high incidence among the Auyw and Jakai people of West New Guinea. Neurology 1982; 32: 107-126.
  • McCeer PL, Schwab C, McGeer EG, Haddock RL, Steele JC. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam. Neurology 1997; 49: 400-409.
  • Lizirik DL, Spencer P, Kisby GE. Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases. Biochem Pharmacol 1996; 51: 1585-1591.
  • Iwata S, Sasajima K, Yase Y, et al. Studies of amyotrophic lateral sclerosis by neutron activation analysis and X-ray microanalysis. Ann Rep Res Reactor lnst Kyoto Univ 1976; 9: 44-54.
  • Yanagihara R, Garruto RM, Gajdusek DC, et al. Calcium and vitamin D metabolism in Guamian Chamorros with amyotrophic lateral sclerosis and Parkinsonism-dementia. Ann Neurol 1984; 15: 42-48.
  • Yase Y. Metal studies of ALS. Further development. In: Tsubaki T, Yase Y, eds. Amyotrophic Lateral Sclerosis: Recent advances in research and development. Amsterdam: Excerpta Medica, 1988: 59-65.
  • Mayor GH, Remedi RF, Sprague SM, et al. Central nervous system manifestations of aluminium: effect of parathormone. Neurotoxicology 1980; 1: 33-42.
  • Nakagawa S, Yoshida S, Suematsu C, et al. The calciummagnesium deficient rat: a study on the distribution of calcium in the spinal cord using the electron probe microanalyser. Experientia 1977; 33: 1225-1226.
  • Zhang ZX, Anderson DW, Mantel N, Roman GC. Motor neuron disease on Guam: geographic and familial occurrence 1956-85. Acta Neurol Scand 1996; 94: 51-59.
  • Yoshida S, Uebayashi Y, Kihira T, et al. Epidemiology of motor neuron disease in the Ku peninsula of Japan, 1989-: 993: active or disappearing focus? J Neurol Sci 1998; 155: 146-155.
  • Kondo K. Epidemiology of motor neuron disease. In: Leigh PN, Swash M, eds. Motor Neuron Disease: Biology and management. London: Springer, 1995: 19-33.
  • Spencer PS, Alien CN, Kisby GE, et al. Lathyrism and Western Pacific amyotrophic lateral sclerosis: etiology of short and long latency motor system disorders. In: Rowland LP, ed. Amyotrophic lateral sclerosis and other motor neuron diseases. (Advances in Neurology, Vol. 56). New York: Raven Press 1991, pp. 287-310.
  • Tylleskar T, Banea M, Bikanji N, et al. Cassava cyanogens and konzo, an upper motor neuron disease found in Africa. Lancet 1992; 339: 208-211.
  • Camu W, Khoris J, Moulard B, et al. Genetics of familial ALS and consequences for diagnosis. J Neurol Sci 1999; 165:821-826.
  • Mitchell JD, Gatt JA, Phillips TM, et al. Cu/Zn Superoxide dismutase, free radicals and motoneuron disease. Lancet 1993; 342: 1051-1052.
  • Shaw IC, Fitzmaurice PS, Mitchell JD, Lynch PG. Amyotrophic lateral sclerosis: a defect in cellular free radical protection mechanisms. Neurodegeneration 1995; 4: 391-396.
  • Liu Y, Brooks BR, Taniguchi N, et al. CuZnSOD and MnSOD immunoreactivity in brain stem motor neurons from amyotrophic lateral sclerosis patients. Acta Neuropathol (Berl) 1998; 95: 65-70.
  • Parboosingh JS, Rouleau GA, Meninger V, et al. Absence of mutations in the Mn Superoxide dismutase or catalase genes in familial amyotrophic lateral sclerosis. Neuromuscular Disorders 1995; 5: 7-10.
  • Robbins JH, Otsuka F, Tarone RE, et al. Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines. J Neurol Neurosurg Psychiatry 1985; 48: 916-923.
  • Mithal NP, Radunovic A, Figlewicz DA, McMillan TJ, Leigh PN. Cells from SOD-1 associated amyotrophic lateral sclerosis do not have an increased susceptibility to radiationinduced free radical production or DNA damage. J Neurol Sci 1999; 164: 89-92.
  • Glenn SA, Ross MA. Delayed radiation-induced bulbar palsy mimicking ALS. Muscle & Nerve 2000; 5: 814-817.
  • Drachman DB, Chaudiy V, Cornblath D, et al. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol 1994; 35: 142-150.
  • Berger MM, Kopp N, Vital C, et al. Detection and cellular localisation of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000; 54: 20-25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.